PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Current features

Patient-Derived Tumour Organoids for Precision Screening: Operationalising GxPLevel Quality for Translational Reliability

There is a persistent gap between preclinical promise and clinical reality in oncology drug development. Two-dimensional cell culture systems derived from animal mod...
Continue Reading →
Current features

Optimising Clinical Trials for the Era of Self-Injectable Combination Products

Self-administered injectable drug–device combination (DDC) products are entering a phase of accelerated therapeutic innovation. Demographic change, chronic disease t...
Continue Reading →
Current features

Next-Generation Risk-Based Monitoring: The Role of AI in Clinical Trial Oversight

Clinical trial monitoring has traditionally relied on routine on site visits and exhaustive source data verification (SDV) to ensure patients’ safety and data integr...
Continue Reading →
Current features

From Start-up to Sustainability: The New Reality of Research Site Operations

From Episodic Challenges to Structural Conditions in Clinical Research sites remain indispensable as the operational backbone of the clinical trial ecosystem. They a...
Continue Reading →
Current features

Artificial Intelligence and Ethical Review

As artificial intelligence (AI) becomes increasingly integrated into clinical research, Institutional Review Boards (IRBs) face new challenges in evaluating associat...
Continue Reading →
Current features

Communication is Key to Unlocking Clinical Trial Success

The importance of clear, consistent communication between contract research organisations (CRO), sponsors and trial sites cannot be stressed enough. Effective collab...
Continue Reading →
Current features

Embracing Quantitative Signal Detection Methods as a Smaller MAH

The major regulators have a minimum expectation that all pharma companies will be taking a proactive approach to real-world safety monitoring. As part of this, they ...
Continue Reading →
Current features

Overcoming Drug Distribution Hurdles in Hard-to-reach Clinical Trial Markets

Africa’s position in the global drug development landscape is transforming. Increasingly, sponsors are viewing the region through the lens of opportunity, especially...
Continue Reading →
Current features

Future of Blockchain Technology in Clinical Trials

Nowadays, when everything seems to be about artificial intelligence (AI), it is easy to forget that there are other technologies that will likely impact on how clini...
Continue Reading →
Current features

Transforming Clinical Operations through the Synergy of Generative and Agentic AI

Artificial Intelligence (AI) continues to evolve at an unprecedented pace, reshaping the way organisations operate, innovate, and make decisions. Among its most tran...
Continue Reading →
Quotient